172823-76-6 Usage
Description
2-Piperidinecarboxylic acid, 4-methyl-(9CI), also known as 4-Methyl-2-piperidinecarboxylic acid, is an organic compound with a molecular structure that features a piperidine ring and a carboxylic acid group. It is characterized by its potential applications in various fields, particularly in pharmaceutical and chemical research.
Uses
Used in Pharmaceutical Research:
2-Piperidinecarboxylic acid, 4-methyl-(9CI) is used as a reactant for the synthesis of anti-viral agents. Its unique molecular structure allows it to be a key component in the development of new drugs that target viral infections, potentially leading to more effective treatments for various viral diseases.
Used in Analytical Chemistry:
In the field of analytical chemistry, 2-Piperidinecarboxylic acid, 4-methyl-(9CI) is utilized in capillary electrophoretic mobility shift displacement assays. This technique is employed for assessing weak drug-protein interactions, which is crucial for understanding the binding properties and potential efficacy of new drug candidates.
Check Digit Verification of cas no
The CAS Registry Mumber 172823-76-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,8,2 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 172823-76:
(8*1)+(7*7)+(6*2)+(5*8)+(4*2)+(3*3)+(2*7)+(1*6)=146
146 % 10 = 6
So 172823-76-6 is a valid CAS Registry Number.
172823-76-6Relevant articles and documents
Synthesis and biological evaluation of substituted 4-(OBz)phenylalanine derivatives as novel N-type calcium channel blockers
Hu, Lain-Yen,Ryder, Todd R.,Nikam, Sham S.,Millerman, Elizabeth,Szoke, Balazs G.,Rafferty, Michael F.
, p. 1121 - 1126 (2007/10/03)
Selective N-type Voltage Activated Calcium Channel (VACC) blockers have shown utility in several models of stroke and pain. In the process of searching for small molecules as N-type calcium channel blockers, we have identified a series of N,N-dialkylpeptidylamines (e.g., PD 175069) with potent functional activity at N-type VACC. Further modification of the leucine moiety of PD 175069 with a cyclized ring structure provides a series of novel molecules. Syntheses and pharmacological evaluation of the series are presented.
